(Q52840563)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17235319%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

title

Type I interferon inhibits antibody responses induced by a chimpanzee adenovirus vector (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17235319%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

1 reference

1 reference

0 references

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17235319%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

8

Robert H Silverman

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17235319%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

author name string

Scott E Hensley

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17235319%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

Ann S Cun

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17235319%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

Wynetta Giles-Davis

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17235319%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

Yan Li

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17235319%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

Zhiquan Xiang

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17235319%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

Marcio O Lasaro

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17235319%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

Hildegund C J Ertl

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17235319%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

publication date

1 February 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17235319%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17235319%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

volume

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17235319%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17235319%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

page(s)

393-403

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17235319%20AND%20SRC:MED&resulttype=core&format=json

Adenoviruses as vaccine vectors

24 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300024

7 January 2021

A replication-defective human adenovirus recombinant serves as a highly efficacious vaccine carrier.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300024

7 January 2021

Novel, chimpanzee serotype 68-based adenoviral vaccine carrier for induction of antibodies to a transgene product

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300024

7 January 2021

Development of a preventive vaccine for Ebola virus infection in primates

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300024

7 January 2021

Chimpanzee adenovirus vaccine protects against Zaire Ebola virus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300024

7 January 2021

Protection against P. aeruginosa with an adenovirus vector containing an OprF epitope in the capsid.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300024

7 January 2021

Human immunodeficiency virus type 1-specific immune responses in primates upon sequential immunization with adenoviral vaccine carriers of human and simian serotypes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300024

7 January 2021

Multiclade human immunodeficiency virus type 1 envelope immunogens elicit broad cellular and humoral immunity in rhesus monkeys

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300024

7 January 2021

Complete, long-lasting protection against malaria of mice primed and boosted with two distinct viral vectors expressing the same plasmodial antigen

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300024

7 January 2021

Immunogenicity and protection of a recombinant human adenovirus serotype 35-based malaria vaccine against Plasmodium yoelii in mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300024

7 January 2021

Early role of CD4+ Th1 cells and antibodies in HER-2 adenovirus vaccine protection against autochthonous mammary carcinomas.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300024

7 January 2021

Replication-defective vector based on a chimpanzee adenovirus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300024

7 January 2021

Dendritic cells and the control of immunity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300024

7 January 2021

Lymphokine control of in vivo immunoglobulin isotype selection.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300024

7 January 2021

Blood dendritic cells interact with splenic marginal zone B cells to initiate T-independent immune responses.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300024

7 January 2021

DCs induce CD40-independent immunoglobulin class switching through BLyS and APRIL

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300024

7 January 2021

Dendritic cell maturation, but not CD8+ T cell induction, is dependent on type I IFN signaling during vaccination with adenovirus vectors.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300024

7 January 2021

Efficient transduction of human monocyte-derived dendritic cells by chimpanzee-derived adenoviral vector.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300024

7 January 2021

Recombinant adenoviral vectors turn on the type I interferon system without inhibition of transgene expression and viral replication.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300024

7 January 2021

Type i interferons potently enhance humoral immunity and can promote isotype switching by stimulating dendritic cells in vivo.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300024

7 January 2021

Plasmacytoid dendritic cells induce plasma cell differentiation through type I interferon and interleukin 6

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300024

7 January 2021

TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300024

7 January 2021

Dendritic-cell control of pathogen-driven T-cell polarization

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300024

7 January 2021

A type I interferon autocrine-paracrine loop is involved in Toll-like receptor-induced interleukin-12p70 secretion by dendritic cells.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300024

7 January 2021

Enhanced breadth of CD4 T-cell immunity by DNA prime and adenovirus boost immunization to human immunodeficiency virus Env and Gag immunogens

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300024

7 January 2021

Molecular cloning and characterization of the human double-stranded RNA-activated protein kinase induced by interferon

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300024

7 January 2021

Effect of virus-induced interferon on the antibody response of suckling and adult mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300024

7 January 2021

Host genotype influences immunomodulation by interferon

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300024

7 January 2021

Cutting edge: enhancement of antibody responses through direct stimulation of B and T cells by type I IFN.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300024

7 January 2021

Molecular basis of the inflammatory response to adenovirus vectors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300024

7 January 2021

Adenovirus efficiently transduces plasmacytoid dendritic cells resulting in TLR9-dependent maturation and IFN-alpha production

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300024

7 January 2021

Promoter attenuation in gene therapy: interferon-gamma and tumor necrosis factor-alpha inhibit transgene expression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300024

7 January 2021

Identification of murine CD8 T cell epitopes in codon-optimized SARS-associated coronavirus spike protein

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300024

7 January 2021

Functional role of type I and type II interferons in antiviral defense

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300024

7 January 2021

Deficient signaling in mice devoid of double-stranded RNA-dependent protein kinase

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300024

7 January 2021

Interferon action and apoptosis are defective in mice devoid of 2',5'-oligoadenylate-dependent RNase L

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300024

7 January 2021

Chimpanzee-origin adenovirus vectors as vaccine carriers.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300024

7 January 2021

An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300024

7 January 2021

Mouse type I IFN-producing cells are immature APCs with plasmacytoid morphology

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300024

7 January 2021

Limited entry of adenovirus vectors into well-differentiated airway epithelium is responsible for inefficient gene transfer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300024

7 January 2021

Immune effector mechanisms required for protection to rabies virus.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300024

7 January 2021